Across
- 3. Immunity that every person's body make.
- 5. Alternative drug in adult patients during pregnancy.
- 7. Related to opportunistic pathogens experienced by low percentage of patients in ART.
- 8. Life cycle wherein RNA polymerase creates a copies of HIV genomic material.
- 10. Type of infection wherein patients are more vulnerable to infections and malignancies
- 13. First-choiceof drug in Protein Inhibitor
- 14. HIV enzymes that cuts long chain of HIV proteins.
- 19. Drug associated with potentially life-threatening and fatal skin reactions.
- 21. Short-term protection against a specific antigen.
- 23. Acts by interfereing with HIV viral RNA-dependent DNA polymerase.
- 24. New copies of HIV can now infect other cells.
- 26. The most effective and long lasting type of immunity
- 27. First-choice drug within the NNRTI class.
Down
- 1. Drugs hat limits the ability of virus to replicate and infect new cell.
- 2. Necessary for the virus to bind to CD4
- 4. Inhibiting the activity of protease.
- 5. Prevent viral replication by competing with binding of the reverse transcriptase enzyme.
- 6. Wasting of fat.
- 9. The newly assembled virus pushes out "buds" from the host cell.
- 11. Cell that the HIV destroys.
- 12. A blueprint to amke long chains of HIV proteins.
- 15. Vaccinations to tetanus, measles, smallpox etc.
- 16. Tuberculosis, bacterial pneumonia, septicemia.
- 17. Common side effect of raltegavir.
- 18. Cytomegalovirus, herpes simplex, herpes zoster.
- 20. Only agent approved in Entry Inhibitor.
- 22. HIV enzyme that hides the HIV DNA within the host cell.
- 25. Type of immunity when antigen enters the body w/o human assistance.
